These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 1756196)

  • 21. Neuroendocrine evidence for reduced serotonergic neurotransmission during heavy drinking.
    Balldin J; Berggren U; Engel J; Eriksson M
    Alcohol Clin Exp Res; 1994 Aug; 18(4):822-5. PubMed ID: 7978090
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sex-linked differences in cortisol, ACTH and prolactin responses to 5-hydroxy-tryptophan in healthy controls and minor and major depressed patients.
    Maes M; Vandewoude M; Schotte C; Maes L; Martin M; Blockx P
    Acta Psychiatr Scand; 1989 Dec; 80(6):584-90. PubMed ID: 2559587
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Different serotonin receptor types participate in 5-hydroxytryptophan-induced gonadotropins and prolactin release in the female infantile rat.
    Lacau-Mengido IM; Libertun C; Becú-Villalobos D
    Neuroendocrinology; 1996 May; 63(5):415-21. PubMed ID: 8738578
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Specificity of ethanollike effects elicited by serotonergic and noradrenergic mechanisms.
    Krystal JH; Webb E; Cooney N; Kranzler HR; Charney DS
    Arch Gen Psychiatry; 1994 Nov; 51(11):898-911. PubMed ID: 7944878
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Involvement of the 5-HT2 receptor in the 5-HT receptor-mediated stimulation of prolactin release.
    Albinsson A; Palazidou E; Stephenson J; Andersson G
    Eur J Pharmacol; 1994 Jan; 251(2-3):157-61. PubMed ID: 8149973
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential effect of serotonin 5-HT(1A) receptor antagonists on the secretion of corticotropin and prolactin.
    Jørgensen H; Kjaer A; Warberg J; Knigge U
    Neuroendocrinology; 2001 May; 73(5):322-33. PubMed ID: 11399905
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The serotonin hypothesis of obsessive compulsive disorder.
    Barr LC; Goodman WK; Price LH
    Int Clin Psychopharmacol; 1993 Nov; 8 Suppl 2():79-82. PubMed ID: 8201248
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of 5-hydroxytryptophan on serum cortisol levels in major affective disorders. I. Enhanced response in depression and mania.
    Meltzer HY; Umberkoman-Wiita B; Robertson A; Tricou BJ; Lowy M; Perline R
    Arch Gen Psychiatry; 1984 Apr; 41(4):366-74. PubMed ID: 6608335
    [TBL] [Abstract][Full Text] [Related]  

  • 29. D-fenfluramine-induced prolactin and cortisol release in major depression: response to treatment.
    O'Keane V; McLoughlin D; Dinan TG
    J Affect Disord; 1992 Nov; 26(3):143-50. PubMed ID: 1460163
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of selective serotonin (5-HT) agonists and 5-HT2 antagonist on prolactin secretion.
    Van de Kar LD; Lorens SA; Urban JH; Bethea CL
    Neuropharmacology; 1989 Mar; 28(3):299-305. PubMed ID: 2524677
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mediation of ACTH and prolactin responses to 5-HTP by 5-HT2 receptors.
    Gartside SE; Cowen PJ
    Eur J Pharmacol; 1990 Apr; 179(1-2):103-9. PubMed ID: 2163847
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clomipramine enhances the cortisol response to 5-HTP: implications for the therapeutic role of 5-HT2 receptors.
    Sargent PA; Quested DJ; Cowen PJ
    Psychopharmacology (Berl); 1998 Nov; 140(1):120-2. PubMed ID: 9862411
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Placebo-controlled comparison of three dose-regimens of 5-hydroxytryptophan challenge test in healthy volunteers.
    Gijsman HJ; van Gerven JM; de Kam ML; Schoemaker RC; Pieters MS; Weemaes M; de Rijk R; van der Post J; Cohen AF
    J Clin Psychopharmacol; 2002 Apr; 22(2):183-9. PubMed ID: 11910264
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of selective serotonin receptor agonists on prolactin secretion in male rats.
    Jørgensen H; Knigge U; Warberg J
    Neuroendocrinology; 1993 Mar; 57(3):401-7. PubMed ID: 8321411
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anxiogenic effects of m-CPP in patients with panic disorder: comparison to caffeine's anxiogenic effects.
    Klein E; Zohar J; Geraci MF; Murphy DL; Uhde TW
    Biol Psychiatry; 1991 Nov; 30(10):973-84. PubMed ID: 1756202
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interactions of histaminergic and serotonergic neurons in the hypothalamic regulation of prolactin and ACTH secretion.
    Jørgensen H; Knigge U; Kjaer A; Warberg J
    Neuroendocrinology; 1996 Nov; 64(5):329-36. PubMed ID: 8930933
    [TBL] [Abstract][Full Text] [Related]  

  • 37. D-fenfluramine-induced prolactin responses in postwithdrawal alcoholics and controls.
    Farren CK; Ziedonis D; Clare AW; Hammeedi FA; Dinan TG
    Alcohol Clin Exp Res; 1995 Dec; 19(6):1578-82. PubMed ID: 8749830
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacology of rising oral doses of 5-hydroxytryptophan with carbidopa.
    Smarius LJ; Jacobs GE; Hoeberechts-Lefrandt DH; de Kam ML; van der Post JP; de Rijk R; van Pelt J; Schoemaker RC; Zitman FG; van Gerven JM; Gijsman HJ
    J Psychopharmacol; 2008 Jun; 22(4):426-33. PubMed ID: 18308795
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of the serotonin agonist, MK-212, on body temperature in schizophrenia.
    Lee HS; Bastani B; Friedman L; Ramirez L; Meltzer HY
    Biol Psychiatry; 1992 Mar; 31(5):460-70. PubMed ID: 1581424
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of 5-hydroxytryptophan on prolactin and growth hormone release in the infant rat: evidence for different neurotransmitter mediation.
    Cocchi D; Gil-Ad I; Panerai AE; Locatelli V; Müller EE
    Neuroendocrinology; 1977; 24(1):1-13. PubMed ID: 23503
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.